Brown Medical School Hematology-Oncology Fellowship Dear Visitor, Welcome to the Brown Medical School Hematology-Oncology Fellowship website. Important information regarding the Brown Fellowship is provided below. You will find descriptions of the training program, the participating hospitals, and research opportunities. Application materials and program requirements are also available. This website will introduce you to our program and will describe our two-fold mission: To provide excellent training in clinical Hematology and Oncology To provide outstanding research opportunities. Graduating fellows are well-equipped to pursue scholarly academic careers and for the clinical practice of Hematology and Medical Oncology. Thank you for your interest in the Brown University Hematology-Oncology Fellowship. We look forward to hearing from you. Regards, Anthony Mega, MD Program Information The Brown Medical School Hematology-Oncology Fellowship Training Program offers training toward certification by the American Board of Internal Medicine in Hematology and Medical Oncology. Most trainees elect three years of training, which makes them eligible for certification in both subspecialties; a two year training program leading to certification in either Hematology or Medical Oncology is also available. Candidates for the Fellowship must be Board Eligible or Board Certified in Internal Medicine. The Program uses the facilities and faculty of four Brown Medical School teaching hospitals: Rhode Island Hospital, The Miriam Hospital, Memorial Hospital of Rhode Island, and the Providence Veterans Administration Hospital. Fellows gain a broad perspective in Hematology and Oncology by working closely with the faculty, the diverse patient populations, and the clinical and laboratory research at the various hospitals. Additional rotations include the Bone Marrow Transplant Units at New England Medical Center (Boston) and at Roger Williams Medical Center (Providence) and elective rotations in Radiation Oncology, Pediatric Hematology and Oncology, Gynecologic Oncology (at Women & Infants Hospital, Providence), Hematopathology, Blood Banking, and others. All fellows are required to actively participate in either laboratory or clinical research. Most fellows choose clinical research and they assume a major role in a clinical research project through the regional cooperative oncology group, Brown University Oncology Group. Laboratory research opportunities exist at several of the hospitals and at the nearby Brown University campus, and time is available during the second and third years of training for those fellows who choose laboratory research. There is a full schedule of clinical, educational, and research conferences. Hematology Oncology Grand Rounds is a weekly conference of state-of-the-art presentations by fellows, Brown faculty, and visiting faculty. Other educational conferences include weekly Morning Report (clinical management of challenging cases), monthly Hematopathology Conference, monthly Hemostasis Conference, and others. Fellows and faculty discuss current literature in the monthly Journal Club. Each hospital has its own schedule of Tumor Boards and other teaching conferences. Each fellow has an outpatient clinic at one of the participating hospitals, in which he or she follows a group of patients throughout the fellowship. Additional outpatient clinics, including specialty clinics, are scheduled in the latter years of the fellowship. Graduating fellows are well equipped to pursue clinical academic careers and the clinical practice of Hematology and Medical Oncology. Approximately one half of recent trainees have entered academic careers, but others have pursued advanced training in stem cell transplantation, entered private practice, or worked in the pharmaceutical industry. Any questions pertaining to the fellowship should be directed to: Patricia Blade Program Administrator The Miriam Hospital, E215 164 Summit Ave Providence, RI 02906 401-793-4648 pblade@lifespan.org Applications are accepted from December 1st 2007 until March 1st 2008.